Novavax Does It Again!

Shares of Novavax Inc. (NVAX) set a fresh record high of $235.50 on Friday as investors cheered the company’s coronavirus vaccine trial results. The company’s protein-based COVID-19 vaccine candidate, NVX-CoV2373,

Continue reading »